Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Emergex Vaccines Holding Ltd.

http://www.emergexvaccines.com/

Latest From Emergex Vaccines Holding Ltd.

Coronavirus Notebook: UK Reports Impressive Booster Results, Drones Deliver Vaccines In Africa

Emergex is preparing to begin a Phase I study of its T-cell priming vaccine, RedHill BioPharma has completed enrolment in a Phase II/III study of upamostat, and Australia is assessing Moderna’s Spikevax for use in 6-11 year olds.

United Kingdom Australia

Finance Watch: Three Newly Public Companies Face Mixed Reception In Early Trading

Also, two more health care-focused SPACs went public, Centessa obtained up to $300m in debt, three new venture capital funds launched and Intergalactic debuted with a $75m series A round.

Financing Business Strategies

IPO Update: Average Return Turns Negative For Newly Public Biopharma Firms

With 88 initial public offerings in the US through the end of the third quarter of 2021, the biopharma industry is two IPOs ahead of the full-year 2020 total, but with an average return of -4% momentum may slow.

Financing Business Strategies

Coronavirus Update: Moderna Secures Third Approval In Israel, World Leader In COVID-19 Vaccinations

Moderna has just secured its third global authorization for its COVID-19 vaccination in Israel, while the European Medicines Agency's review has been delayed.

Coronavirus COVID-19 Companies
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Other Names / Subsidiaries
    • Emergex Vaccines Holding Limited, ImmProNano Inc.
UsernamePublicRestriction

Register